Can l-carnitine reduce post-COVID-19 fatigue?
A significant number of patients infected with the new coronavirus suffer from chronic fatigue syndrome after COVID-19, and their symptoms may persist for months after the infection. Nevertheless, no particular treatment for post-disease fatigue has been found. At the same time, many clinical trials...
Gespeichert in:
Veröffentlicht in: | Annals of medicine and surgery 2022-01, Vol.73, p.103145-103145, Article 103145 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A significant number of patients infected with the new coronavirus suffer from chronic fatigue syndrome after COVID-19, and their symptoms may persist for months after the infection. Nevertheless, no particular treatment for post-disease fatigue has been found. At the same time, many clinical trials have shown the effectiveness of l-carnitine in relieving fatigue caused by the treatment of diseases such as cancer, MS, and many other diseases. Therefore, it can be considered as a potential option to eliminate the effects of fatigue caused by COVID-19, and its consumption is recommended in future clinical trials to evaluate its effectiveness and safety.
•The coronavirus disease is a viral infection that could induce different respiratory.•A significant number of patients infected with the new coronavirus suffer from chronic fatigue.•Clinical trials have shown the effectiveness of L-carnitine in relieving fatigue. |
---|---|
ISSN: | 2049-0801 2049-0801 |
DOI: | 10.1016/j.amsu.2021.103145 |